Associate Director, Clinical Biomarker Development

Responsibilities

• Develop and maintain translational and clinical biomarker strategies to support portfolio assets from phase 1 to phase 3 studies
• Support biomarker-related aspects of trial design, including assay development, patient sample acquisition, and study protocols
• Participate in cross-functional teams such as clinical working groups and clinical study execution teams
• Work with internal translational groups, CROs, and collaborators to develop and validate assays for clinical use
• Manage outsourcing to CROs, including scope of work, contracting, budgets, and timelines
• Collaborate with Clinical Bioinformatics and Cancer Genomics to support analysis of biomarker readouts

Requirements

• Ph.D. in cancer biology, cell/molecular biology, genomics, or equivalent
• 3+ years of clinical biomarker and/or assay development experience in industry
• Proven track record in the development, validation, and clinical implementation of biomarker readouts
• Experience working with Contract Research Organizations (CROs)
• Strong scientific, business, and interpersonal communication skills

Preferred Qualifications

• Experience with targeted oncology therapies or RAS/MAPK pathway biology
• Biological understanding of pancreatic, non-small cell lung, and/or colorectal cancers
• Familiarity with genomic, transcriptomic, and proteomic biomarker platforms
• Familiarity with analytical software for integrating clinical and biomarker datasets

About the Company

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.